Save your place

Sign in to WhoBought

Please try again later.

Passage Bio, Inc. (PASG) institutional ownership

Latest close $4.62 Jul 27, 2026
Market cap$27M 52-week range SectorHealthcare
Funds holding · Q1 2026
27
reported PASG position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
16 buyers · 11 sellers

Passage Bio, Inc. (PASG) price and institutional activity

Dates

Q1 2026

$0 bought by 16 investors
Ikarian Capital, LLCYiheng Capital Management, L.P. +14 more
$0 sold by 11 investors
Citadel Advisors LLCNorthern Trust +9 more
Bought Sold Totals per quarter; hover a bar for the names.

Passage Bio, Inc. (PASG) institutional activity · 27

Investor Type Est. change Change Δ Own Date
Ikarian Capital, LLC · New
Change +68K Date Q1 2026
Ikarian Capital, LLC New· Q1 2026 +68K Q1 2026
Yiheng Capital Management, L.P. · Added
Change +52K Date Q1 2026
Yiheng Capital Management, L.P. Added· Q1 2026 +52K Q1 2026
UBS Group AG · Added
Change +26K Date Q1 2026
UBS Group AG Added· Q1 2026 +26K Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +25K +22.5% Q1 2026
Verdad Advisers, LP · New
Change +22K Date Q1 2026
Verdad Advisers, LP New· Q1 2026 +22K Q1 2026
Diadema Partners LP · New
Change +20K Date Q1 2026
Diadema Partners LP New· Q1 2026 +20K Q1 2026
Boothbay Fund Management, LLC · New
Change +19K Date Q1 2026
Boothbay Fund Management, LLC New· Q1 2026 +19K Q1 2026
Citadel Advisors LLC Exited· Q1 2026 −18K −100.0% Q1 2026
Northern Trust · Exited
Change −14K Δ Own −100.0% Date Q1 2026
Northern Trust Exited· Q1 2026 −14K −100.0% Q1 2026
Xtx Topco Ltd · New
Change +13K Date Q1 2026
Xtx Topco Ltd New· Q1 2026 +13K Q1 2026
Quadrature Capital Ltd · Exited
Change −13K Δ Own −100.0% Date Q1 2026
Quadrature Capital Ltd Exited· Q1 2026 −13K −100.0% Q1 2026
Squarepoint Ops LLC · Exited
Change −11K Δ Own −100.0% Date Q1 2026
Squarepoint Ops LLC Exited· Q1 2026 −11K −100.0% Q1 2026
Nano Cap New Millennium Growth Fund L P · Exited
Change −10K Δ Own −100.0% Date Q1 2026
Nano Cap New Millennium Growth Fund L P Exited· Q1 2026 −10K −100.0% Q1 2026
Geode · Added
Change +10K Date Q1 2026
Geode Added· Q1 2026 +10K Q1 2026
Eversept Partners, LP · Added
Change +5K Date Q1 2026
Eversept Partners, LP Added· Q1 2026 +5K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 27

Famous investor activity in Passage Bio, Inc. (PASG)

Passage Bio, Inc. (PASG) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Lynx1 Capital Management LP · 10% Owner Buy +$206K
Price $4.12 Qty +50K Owned 674K ΔOwn +8.0% Trade date Jun 25, 2026 Filed date Jun 29, 2026
Lynx1 Capital Management LP 10% Owner Buy $4.12 +50K +$206K 674K +8.0% Jun 25, 2026 Jun 29, 2026
Sondhi Dolan · Director Grant (A) 11K
Owned 11K Trade date May 19, 2026 Filed date May 21, 2026
Sondhi Dolan Director Grant (A) 11K 11K May 19, 2026 May 21, 2026
Porter Derrell · Director Grant (A) 11K
Owned 11K Trade date May 19, 2026 Filed date May 21, 2026
Porter Derrell Director Grant (A) 11K 11K May 19, 2026 May 21, 2026
Kassberg Thomas Richard · Director Grant (A) 11K
Owned 11K Trade date May 19, 2026 Filed date May 21, 2026
Kassberg Thomas Richard Director Grant (A) 11K 11K May 19, 2026 May 21, 2026
Kapadia Sandip · Director Grant (A) 11K
Owned 11K Trade date May 19, 2026 Filed date May 21, 2026
Kapadia Sandip Director Grant (A) 11K 11K May 19, 2026 May 21, 2026
Gowen Maxine · Director Grant (A) 11K
Owned 11K Trade date May 19, 2026 Filed date May 21, 2026
Gowen Maxine Director Grant (A) 11K 11K May 19, 2026 May 21, 2026
Countouriotis Athena · Director Grant (A) 11K
Owned 11K Trade date May 19, 2026 Filed date May 21, 2026
Countouriotis Athena Director Grant (A) 11K 11K May 19, 2026 May 21, 2026
Borthwick Kathleen · Officer Grant (A) 16K
Owned 16K Trade date Mar 16, 2026 Filed date Mar 18, 2026
Borthwick Kathleen Officer Grant (A) 16K 16K Mar 16, 2026 Mar 18, 2026
Chou William · Director Grant (A) 58K
Owned 58K Trade date Mar 16, 2026 Filed date Mar 18, 2026
Chou William Director Grant (A) 58K 58K Mar 16, 2026 Mar 18, 2026
Chou William · Director, Officer Sell −$75K
Price $18.44 Qty −4K Owned 7K Trade date Jan 8, 2026 Filed date Jan 12, 2026
Chou William Director, Officer Sell $18.44 −4K −$75K 7K Jan 8, 2026 Jan 12, 2026
Chou William · Director, Officer 2 operations 0
Owned 10K Trade date Jan 8, 2026 Filed date Jan 12, 2026
Chou William Director, Officer 2 operations 0 10K Jan 8, 2026 Jan 12, 2026
Borthwick Kathleen · Officer Sell −$38K
Price $18.44 Qty −2K Owned 5K Trade date Jan 8, 2026 Filed date Jan 12, 2026
Borthwick Kathleen Officer Sell $18.44 −2K −$38K 5K Jan 8, 2026 Jan 12, 2026
Borthwick Kathleen · Officer 2 operations 0
Owned 5K Trade date Jan 8, 2026 Filed date Jan 12, 2026
Borthwick Kathleen Officer 2 operations 0 5K Jan 8, 2026 Jan 12, 2026
Nichols Weston · 10% Owner Buy +$83K
Price $6.99 Qty +12K Owned 624K Trade date Sep 15, 2025 Filed date Sep 15, 2025
Nichols Weston 10% Owner Buy $6.99 +12K +$83K 624K Sep 15, 2025 Sep 15, 2025
Nichols Weston · 10% Owner Buy +$138K
Price $6.99 Qty +20K Owned 612K Trade date Sep 12, 2025 Filed date Sep 15, 2025
Nichols Weston 10% Owner Buy $6.99 +20K +$138K 612K Sep 12, 2025 Sep 15, 2025
15 of 16
15 of 16 Sign in to continue to older insider transactions.

Passage Bio, Inc. (PASG) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Lynx1 Capital Management LP 624K
% of shares outstanding 19.6% Filing date Nov 14, 2025
Lynx1 Capital Management LP 624K 19.6% Nov 14, 2025
Orbimed Advisors LLC 6.8M
% of shares outstanding 12.6% Filing date May 5, 2022
Orbimed Advisors LLC 6.8M 12.6% May 5, 2022
Baselake Partners, LP 235K
% of shares outstanding 7.3% Filing date Jun 25, 2026
Baselake Partners, LP 235K 7.3% Jun 25, 2026
Deep Track Capital, LP
% of shares outstanding 6.0% Filing date Feb 14, 2022
Deep Track Capital, LP 6.0% Feb 14, 2022
FMR LLC 2.7M
% of shares outstanding 4.9% Filing date Dec 10, 2021
FMR LLC 2.7M 4.9% Dec 10, 2021
Access Industries Holdings LLC 2.6M
% of shares outstanding 4.8% Filing date Feb 14, 2022
Access Industries Holdings LLC 2.6M 4.8% Feb 14, 2022
Lav Prescience Ltd 2.2M
% of shares outstanding 4.1% Filing date Feb 9, 2022
Lav Prescience Ltd 2.2M 4.1% Feb 9, 2022
BlackRock Inc. 1.4M
% of shares outstanding 2.5% Filing date Jul 8, 2022
BlackRock Inc. 1.4M 2.5% Jul 8, 2022
8 of 8

Passage Bio, Inc. (PASG) ownership FAQ

Who owns PASG?

27 reporting institutions disclosed PASG position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.